VRTX Investing Cash Flow

Vertex Pharmaceuticals · Investing Cash Flow

VRTX logo

VRTX Investing Cash Flow

Latest reported-$882.80M
VRTX Cash from Investing (-$25.20M → -$882.80M)
High-resolution chart · PNG

VRTX investing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Investing Cash Flow — Annual fiscal periods (USD)
Period endingInvesting Cash Flow (USD)
-945,400,000
-3,770,000,000
-3,141,700,000
-321,100,000
-340,900,000
99,388,000
-1,235,318,000
-202,158,000
-437,681,000
104,469,000
268,856,000
73,959,000
-54,130,000
-425,817,000
212,412,000
7,301,000
-508,732,000
-360,650,000
405,166,000
-208,471,000
-1,732,000
107,428,000
119,585,000
-15,962,000
-145,087,000
-236,329,000
36,400,000
-20,400,000
-118,800,000
-40,400,000
-29,000,000
-14,100,000
6,700,000
-9,400,000
-25,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.